Drug Markets/Alcaftadine

Alcaftadine

1 NDC across 1 manufacturer|0 Generic,1 Brand

Alcaftadine is used to treat allergic conjunctivitis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jul 28, 2010, and the first generic was approved Jun 23, 2023.

Alcaftadine is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $2.83 to $2.83 per ML. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$2.83 – $2.83

per ML

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ALCAFTADINE

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
LASTACAFT ONCE DAILY 0.25% DRP
$2.8333
per ML
—

Frequently Asked Questions

What is Alcaftadine used to treat?

Alcaftadine is used to treat allergic conjunctivitis, per the National Library of Medicine's MED-RT classification.

When did Alcaftadine become available as a generic?

FDA approved the first generic Alcaftadine (ANDA) on Jun 23, 2023.

How many Alcaftadine products are on the market?

The Alcaftadine drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Alcaftadine?

NADAC reference prices for Alcaftadine range from $2.8333 to $2.8333 per ML.

Which manufacturers make Alcaftadine?

1 manufacturer lists Alcaftadine in NADAC. Ranked by number of NDCs, the largest are Allergan, Inc. (1).